David P Nichols

17PUBLICATIONS
28CO-AUTHORS
Fluid-structure interaction and aeroacousticsRespiratory diseasesInfant and child healthMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 17, 2025
Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.

Scott D Sagel, T Spencer Poore, Brandie D Wagner

|Jul 23, 2024
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.

Nicole Mayer-Hamblett, Alex H Gifford, Margaret Kloster

|Mar 15, 2022
Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without Pseudomonas aeruginosa.

Jonathan D Cogen, Anna V Faino, Frankline Onchiri

|Nov 16, 2021
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.

David P Nichols, Alex C Paynter, Sonya L Heltshe

|Oct 28, 2021
Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial.

David P Nichols, Pradeep K Singh, Arthur Baines

|Jan 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.

Nicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis

Pageof 3

Frequent Collaborators

3 joint publications

Steven M Rowe

2 joint publications

Scott D Sagel

1 joint publications

Scott B Drutman

1 joint publications

Jordan K Abbott